Innovation and Commercialization of Therapeutics for Metabolic Disorders
Conference - Baltimore, MA, US
Gain successful strategies for the technical, regulatory and market access hurdles in developing an anti-obesity drug so your company can take the lead in this market.
IIR's inaugural Innovation and Commercialization of Therapeutics for Metabolic Disorders conference is the first event to deliver insights from the first approved anti-obesity drugs in 13 years.
With an FDA Keynote and multiple case studies on the design and execution of safe and affordable CV outcomes trials, this is your best opportunity to overcome the challenges with developing these drugs and capitalize on this new market potential.
(Courtesy of Marriott Inner Harbor at Camden Yards, via mosomikilup.github.com)
-
Innovation and Commercialization of Therapeutics for Metabolic Disorders
Mon, Feb 11, 2013 - Tue, Feb 12, 2013
Marriott Inner Harbor at Camden Yards
110 South Eutaw Street • Baltimore, Maryland 21201 USA
Contact: 410-962-0202If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
